Back

NOAC: do real world data support our expectations?

26 August 2017 (14:37 - 15:00)
Organised by:
Congress Presentation Part of: Most recent developments in atrial fibrillation management Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Reza Wakili

J. W. Goethe University Frankfurt, Frankfurt (Germany)

3 More presentations in this session

Presentation thumbnail
Antiarrhythmic drugs for atrial fibrillation: current use and my prediction for the future
Professor G. Dan (Bucharest, RO)
Presentation thumbnail
Atrial fibrillation ablation: current experience, recent data and new tools
Professor K. Kuck (Luebeck, DE)
Slides Video
Presentation thumbnail
Hybrid approaches for atrial fibrillation ablation
Professor L. Pison (Genk, BE)
Slides Video

Access the full session

Session thumbnail
Most recent developments in atrial fibrillation management

The Event

Event poster

ESC Congress 2017

26 August 2017 14:37 CET
You may be interested in
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019
thumbnail
Congress Session
Stroke and bleeding risk in atrial fibrillation: walking the tight rope
25 August 2023
thumbnail
Congress Presentation
Plasma levels of direct oral anticoagulants in non-valvular atrial fibrillation patients at the time of acute cardioembolic or bleeding events
28 August 2023
thumbnail
Congress Presentation
Direct oral anticoagulants, all-cause mortality and cardiovascular events in patients with atrial fibrillation with and without obesity: a sub-analysis of the nationwide START registry.
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources